Morphofunctional Assessment in Chronic Metabolic Adipose Disease

SECTION I. General Concepts of Chronic Metabolic Disease

• Overview of chronic metabolic adipose disease: from physiology to clinic
• Chronic metabolic adipose disease. Adipose tissue: the YIN?
• Chronic Metabolic Adipose Disease. Muscle: the YANG?
• Diagnosis, assessment, phenotypes, and distribution patterns of chronic metabolic adipose disease
• Biochemical markers of adipose dysfunction
• Adiposity and its distribution patterns in precision medicine applied to type 2 diabetes
• Clinical scales of chronic metabolic adipose disease

SECTION II. Techniques Used

• Anthropometry and chronic metabolic adipose disease
• BIA and phase angle in chronic metabolic adipose disease
• Nutritional ultrasound® in chronic metabolic adipose disease
• Other reference morphological techniques (DXA, CT, MRI) in chronic metabolic adipose disease. New imaging and adipose tissue definitions
• Morphofunctional Assessment in Chronic Metabolic Adipose Disease
• Muscle function tests in chronic metabolic adipose disease
• Hand dynamometry applied to chronic metabolic adipose disease
• Methodology in morphofunctional research applied to chronic metabolic adipose disease

SECTION III. Clinical Assessment

• Morphofunctional assessment of chronic metabolic adipose disease and diabetes
• Morphofunctional assessment in nephropathy secondary to chronic metabolic adipose disease
• Morphofunctional assessment in sarcopenic obesity
• Morphofunctional assessment in hepatic chronic metabolic adipose disease
• Morphofunctional assessment in respiratory pathology associated with chronic metabolic adipose disease
• Morphofunctional assessment of dyslipidemia in chronic metabolic adipose disease
• Morphofunctional assessment in chronic metabolic adipose disease associated with type 1 diabetes
• Morphofunctional assessment in chronic metabolic adipose disease in gynecologic pathology
• Morphofunctional assessment monitoring (MFAM) in chronic metabolic adipose disease

Currently, we understand obesity as a pathological state caused by an excess of body fat, which underestimates the multidimensionality of the problem. The concept of Chronic Metabolic Adipose Disease (CMAD) better addresses the need to define obesity as a complex, heterogeneous, chronic disease that varies in its pathophysiology, progression, and response to the different therapeutic strategies used.

• It approaches obesity from a multidimensional perspective, combining methodologies of biomarkers, imaging, body composition, and functionality, both of fat mass and muscle mass.
• It offers in-depth reflection, knowledge, vision, and tools to successfully address the CMAD underlying the chronic pathologies that are encountered in daily clinical practice.
• It aims to optimize the methodology, define cutoff points, incorporate evidence into clinical practice guidelines, establish treatment outcomes, and their relationship to morbidity and mortality.

Bellido Guerrero, Diego
Jefe de Servicio Endocrinología y Nutrición. Complejo Hospitalario Universitario de Ferrol (A Coruña).
Profesor asociado. Departamento Ciencias da Saude. Universidad de A Coruña.
Presidente de la Sociedad Española de Obesidad (SEEDO).
Miembro de las Áreas de Conocimiento de Diabetes y Nutrición y del Grupo de Trabajo de Lípidos y Valoración Morfofuncional de la Sociedad Española de Endocrinología y Nutrición (SEEN).

Cano Rodríguez, Isidoro
Especialista en Endocrinología y Nutrición.
Exjefe de Sección de Endocrinología, Complejo Asistencial Universitario de León.

Morales Portillo, Cristobal
Jefe de Servicio de Endocrinología y Nutrición, Hospital Vithas Sevilla, Castilleja de la Cuesta,
Sevilla.

García Almeida, José Manuel
Responsable de la Unidad de Nutrición. Unidad de Gestión Clínica de Endocrinología y Nutrición. Hospital Clínico Universitario Virgen de la Victoria (Málaga).
Jefe de Sección de Endocrinología y Nutrición. Hospital Quironsalud (Málaga).
Profesor Asociado Grado en Medicina. Universidad de Málaga.